|
1
|
Huse JT, Holland E and Deangelis LM:
Glioblastoma: molecular analysis and clinical implications. Annu
Rev Med. 64:59–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang C, Wang C, Chen X, et al: Expression
profile of microRNAs in serum: a fingerprint for esophageal
squamous cell carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mian C, Pennelli G, Fassan M, et al:
MicroRNA profiles in familial and sporadic medullary thyroid
carcinoma: preliminary relationships with RET status and outcome.
Thyroid. 22:890–896. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saito Y, Liang G, Egger G, et al: Specific
activation of microRNA-127 with downregulation of the
proto-oncogene BCL6 by chromatin-modifying drugs in human cancer
cells. Cancer Cell. 9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan LX, Huang XF, Shao Q, et al: MicroRNA
miR-21 overexpression in human breast cancer is associated with
advanced clinical stage, lymph node metastasis and patient poor
prognosis. RNA. 14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tryndyak VP, Ross SA, Beland FA and
Pogribny IP: Down-regulation of the microRNAs miR-34a, miR-127, and
miR-200b in rat liver during hepatocarcinogenesis induced by a
methyl-deficient diet. Mol Carcinog. 48:479–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pan C, Chen H, Wang L, et al:
Down-regulation of miR-127 facilitates hepatocyte proliferation
during rat liver regeneration. PLoS One. 7:e391512012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dixon-McIver A, East P, Mein CA, et al:
Distinctive patterns of microRNA expression associated with
karyotype in acute myeloid leukaemia. PLoS One. 3:e21412008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee JW, Choi CH, Choi JJ, et al: Altered
microRNA expression in cervical carcinomas. Clin Cancer Res.
14:2535–2542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gabriely G, Wurdinger T, Kesari S, et al:
MicroRNA 21 promotes glioma invasion by targeting matrix
metalloproteinase regulators. Mol Cell Biol. 28:5369–5380. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guessous F, Zhang Y, Kofman A, et al:
microRNA-34a is tumor suppressive in brain tumors and glioma stem
cells. Cell Cycle. 9:1031–1036. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu DG, Wang YY, Fan LG, et al: MicroRNA-7
regulates glioblastoma cell invasion via targeting focal adhesion
kinase expression. Chin Med J (Engl). 124:2616–2621.
2011.PubMed/NCBI
|
|
15
|
Quintavalle C, Garofalo M, Zanca C, et al:
miR-221/222 overexpession in human glioblastoma increases
invasiveness by targeting the protein phosphate PTPmu. Oncogene.
31:858–868. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia H, Qi Y, Ng SS, et al: microRNA-146b
inhibits glioma cell migration and invasion by targeting MMPs.
Brain Res. 1269:158–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu N, Zhao X, Liu M, et al: Role of
microRNA-26b in glioma development and its mediated regulation on
EphA2. PLoS One. 6:e162642011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fowler A, Thomson D, Giles K, et al:
miR-124a is frequently down-regulated in glioblastoma and is
involved in migration and invasion. Eur J Cancer. 47:953–963. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kefas B, Godlewski J, Comeau L, et al:
microRNA-7 inhibits the epidermal growth factor receptor and the
Akt pathway and is down-regulated in glioblastoma. Cancer Res.
68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mostowy S and Cossart P: Septins: the
fourth component of the cytoskeleton. Nat Rev Mol Cell Biol.
13:183–194. 2012.PubMed/NCBI
|
|
21
|
Hall PA and Russell SE: The pathobiology
of the septin gene family. J Pathol. 204:489–505. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Elhasid R, Sahar D, Merling A, et al:
Mitochondrial pro-apoptotic ARTS protein is lost in the majority of
acute lymphoblastic leukemia patients. Oncogene. 23:5468–5475.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Garcia-Fernandez M, Kissel H, Brown S, et
al: Sept4/ARTS is required for stem cell apoptosis and tumor
suppression. Genes Dev. 24:2282–2293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu W, Ding X, Chen F, et al: The
phosphorylation of SEPT2 on Ser218 by casein kinase 2 is important
to hepatoma carcinoma cell proliferation. Mol Cell Biochem.
325:61–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mizutani Y, Ito H, Iwamoto I, et al:
Possible role of a septin, SEPT1, in spreading in squamous cell
carcinoma DJM-1 cells. Biol Chem. 394:281–290. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scott M, Hyland PL, McGregor G, Hillan KJ,
Russell SE and Hall PA: Multimodality expression profiling shows
SEPT9 to be overexpressed in a wide range of human tumours.
Oncogene. 24:4688–4700. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jia ZF, Huang Q, Kang CS, et al:
Overexpression of septin 7 suppresses glioma cell growth. J
Neurooncol. 98:329–340. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nagata T, Takahashi Y, Asai S, et al: The
high level of hCDC10 gene expression in neuroblastoma may be
associated with favorable characteristics of the tumor. J Surg Res.
92:267–275. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kremer BE, Adang LA and Macara IG: Septins
regulate actin organization and cell-cycle arrest through nuclear
accumulation of NCK mediated by SOCS7. Cell. 130:837–850. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang H, Colella S, Kurrer M, Yonekawa Y,
Kleihues P and Ohgaki H: Gene expression profiling of low-grade
diffuse astrocytomas by cDNA arrays. Cancer Res. 60:6868–6874.
2000.PubMed/NCBI
|
|
31
|
Xu S, Jia ZF, Kang C, et al: Upregulation
of SEPT7 gene inhibits invasion of human glioma cells. Cancer
Invest. 28:248–258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nagata K, Asano T, Nozawa Y and Inagaki M:
Biochemical and cell biological analyses of a mammalian septin
complex, Sept7/9b/11. J Biol Chem. 279:55895–55904. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bowen JR, Hwang D, Bai X, Roy D and
Spiliotis ET: Septin GTPases spatially guide microtubule
organization and plus end dynamics in polarizing epithelia. J Cell
Biol. 194:187–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim SK, Shindo A, Park TJ, et al: Planar
cell polarity acts through septins to control collective cell
movement and ciliogenesis. Science. 329:1337–1340. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tada T, Simonetta A, Batterton M,
Kinoshita M, Edbauer D and Sheng M: Role of Septin cytoskeleton in
spine morphogenesis and dendrite development in neurons. Curr Biol.
17:1752–1758. 2007. View Article : Google Scholar : PubMed/NCBI
|
